Von Gierke Disease Overview
Learn About Von Gierke Disease
Von Gierke disease is a condition in which the body cannot break down glycogen. Glycogen is a form of sugar (glucose) that is stored in the liver and muscles. It is normally broken down into glucose to give you more energy when you need it.
Von Gierke disease is also called Type I glycogen storage disease (GSD I).
Type I glycogen storage disease; von Gierke's disease
Von Gierke disease occurs when the body lacks the protein (enzyme) that releases glucose from glycogen. This causes abnormal amounts of glycogen to build up in certain tissues. When glycogen is not broken down properly, it leads to low blood sugar.
Von Gierke disease is inherited, which means it is passed down through families. If both parents carry a nonworking copy of the gene related to this condition, each of their children has a 25% (1 in 4) chance of developing the disease. This is called autosomal recessive inheritance.
These are symptoms of von Gierke disease:
- Constant hunger and need to eat often
- Easy bruising and nosebleeds
- Fatigue
- Irritability
- Puffy cheeks, thin chest and limbs, and swollen belly
The goal of treatment is to avoid low blood sugar. Eat frequently during the day, especially foods that contain carbohydrates (starches). Older children and adults may take cornstarch by mouth to increase their carbohydrate intake.
In some children, a feeding tube is placed through their nose into the stomach throughout the night to provide sugars or uncooked cornstarch. The tube can be taken out each morning. Alternatively, a gastrostomy tube (G-tube) can be placed to deliver food directly to the stomach overnight.
A medicine to lower uric acid in the blood and decrease the risk for gout may be prescribed. Your provider may also prescribe medicines to treat kidney disease, high lipids, and to increase the cells that fight infection.
People with von Gierke disease cannot properly break down fruit or milk sugar. It is best to avoid these products.
Urology Group Of Florida LLC
David Weinstein is an Urologist in Lake Worth, Florida. Dr. Weinstein is rated as an Elite provider by MediFind in the treatment of Von Gierke Disease. His top areas of expertise are Von Gierke Disease, Glycogen Storage Disease Type 9, Urothelial Cancer, Prostatectomy, and Ureteroscopy.
Janice Chou is a Neurologist and a Psychiatrist in New York, New York. Dr. Chou has been practicing medicine for over 9 years and is rated as an Elite provider by MediFind in the treatment of Von Gierke Disease. Her top area of expertise is Von Gierke Disease.
Terry Derks practices in Groningen, Netherlands. Derks is rated as an Elite expert by MediFind in the treatment of Von Gierke Disease. Their top areas of expertise are Von Gierke Disease, Medium-Chain Acyl-CoA Dehydrogenase Deficiency, Glycogen Storage Disease Type 3, Glutaric Acidemia Type 2, and Liver Transplant.
More information and support for people with von Gierke disease and their families can be found at:
Association for Glycogen Storage Disease -- www.agsdus.org
With treatment, growth, puberty, and quality of life have improved for people with von Gierke disease. Those who are identified and carefully treated at a young age can live into adulthood.
Early treatment also decreases the rate of severe problems such as:
- Gout
- Kidney failure
- Life-threatening low blood sugar
- Liver tumors
These complications can occur:
- Frequent infection
- Gout
- Kidney failure
- Liver tumors
- Osteoporosis (thinning bones)
- Seizures, lethargy, confusion due to low blood sugar
- Short height
- Underdeveloped secondary sexual characteristics (breasts, pubic hair)
- Ulcers of the mouth or bowel
Contact your provider if you have a family history of glycogen storage disease or early infant death due to low blood sugar.
There is no simple way to prevent glycogen storage disease.
Couples who wish to have a baby may seek genetic counseling and testing to determine their risk for passing on von Gierke disease.
Summary: The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with the aim to provide evidence whether relaxed dietary restrictions of fructose and galactose may be justified in treatment recommendations at least for adults, which would considerably enlarge food choice in everyday life of the patients with...
Published Date: April 08, 2025
Published By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Bonnardeaux A, Bichet DG. Inherited disorders of the renal tubule. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Taal MW, Skorecki K, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 44.
Hijazi G, Kishnani PS. Defects in metabolism of carbohydrates. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 107.
Litwack G. Glycogen and glycogenolysis. In: Litwack G, ed. Human Biochemistry. 2nd ed. Philadelphia, PA: Elsevier; 2022:chap 7.
Mojica A, Weinstock RS. Carbohydrates. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 17.
Pearl PL, DiBacco ML, Gibson KM. Inborn errors of metabolism and the nervous system. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 91.
Scheinman SJ. Genetically based kidney transport disorders. In: Gilbert SJ, ed. National Kidney Foundation's Primer on Kidney Disease. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 37.